Ontario Genomics Names John M. Rafferty as New CEO to Champion Made-in-Ontario Innovation
Ontario Genomics is pleased to announce the appointment of John M. Rafferty as its new President & Chief Executive Officer, effective March 31, 2025. A visionary and dynamic leader with 25 years of experience driving innovation and impact in diverse organizations, John brings extensive experience in advancing transformative initiatives across sectors.
John joins Ontario Genomics following his tenure as President & CEO of CNIB, where he led the organization through a period of unprecedented growth and impact, expanding its national reach and strengthening partnerships across industries. His leadership in fostering innovation, strategic collaborations, and policy advocacy has been instrumental in creating meaningful change for blind individuals and communities across Canada.
As he steps into his new role at Ontario Genomics, John is committed to accelerating the commercialization of innovative genomic technologies and advancing “made-in-Ontario” solutions to address some of the world’s greatest challenges. Under his leadership, Ontario Genomics will continue to build strong partnerships between researchers, industry, and government to unlock the full economic and societal potential of genomics in Ontario and beyond.
We are also pleased to announce the promotion of Dr. Jordan Thomson to Chief Scientific Officer and Head of Commercialization. Jordan steps into his new role after successfully serving as COO for the past thirteen months. Jordan’s deep expertise in genomics technologies and their commercialization pathways, coupled with John’s leadership, will create a powerful team to drive market adoption and impact.
We also extend our deepest gratitude to Stephen Cummings, who has served as Interim President & CEO for the past year. His steadfast leadership has been instrumental in guiding Ontario Genomics through a pivotal period of transition. Stephen’s dedication has strengthened our position as a leader in the genomics ecosystem, and we thank him for his invaluable contributions.
Please join us in welcoming John to Ontario Genomics and watch this space for more exciting news in the weeks ahead!